Physician profile
Luis Angel
NPI 1235246307
$1,114.76
in general payments reported to CMS, 2019-2025
14 companies · $176 in 2025
The $176 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $382 · 2020: $95.25 · 2023: $30.91 · 2024: $430 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $637.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragonix Technologies, INC. | $396.69 | 2024 | Pancreaspak, Sherpapak, Liverguard |
| United Therapeutics Corporation | $146.79 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.93 | 2019-2020 | |
| Boston Scientific Corporation | $117.85 | 2019 | |
| Astellas Pharma US INC | $82.44 | 2019-2024 | Cresemba |
| Merck Sharp & Dohme LLC | $53.95 | 2019-2020 | |
| Advanced Respiratory, INC | $45.50 | 2020 | |
| Genentech USA, INC. | $43.45 | 2019 | |
| Cook Medical LLC | $29.35 | 2019 | |
| Exact Sciences Corporation | $29.35 | 2025 | Cologuard Collection Kit |
| Vapotherm INC | $26.30 | 2019 | |
| Electromed, INC. | $17.16 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Angel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.